Recombinant SARS-CoV-2 Spike anticorps (RBD)
Aperçu rapide pour Recombinant SARS-CoV-2 Spike anticorps (RBD) (ABIN7233209)
Antigène
Voir toutes SARS-CoV-2 Spike AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- RBD
-
Fonction
- Human Anti-SARS-CoV-2 RBD (CR3022) Antibody
-
Specificité
- CR3022 variable regions fused to human IgG1: Heavy chain CR3022 (GenBank: DQ168569.1) - Human Heavy chain IgG1 (UniProtKB/Swiss-Prot: P01857.1) Light chain CR3022 (GenBank: DQ168570.1) - Human kappa chain (UniProtKB/Swiss-Prot: P01834.2)
-
Attributs du produit
- Monoclonal antibody to COVID-19 & SARS-CoV S glycoprotein. Recombinantly expressed in Nicotiana benthamiana plants.
-
Purification
- This product was purified by Protein A affinity chromatography.
-
Pureté
- 90-95 %
-
Immunogène
- SARS-CoV-2 RBD
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 2 mg/mL
-
Buffer
- Phosphate Buffered saline (PBS) 0.1M pH 7.4. Preservative: none
-
Agent conservateur
- Without preservative
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Short term: 2 - 4°C. Long term: -20°C
-
-
- SARS-CoV-2 Spike
Antigène
-